| Comparison Dimension | Conventional Laser (Continuous/Full Coverage) | Fractional Laser |
|---|---|---|
| Mode of Action | Energy uniformly covers the entire treatment area – like "carpet bombing" | Energy is divided into numerous micro-beams, forming microscopic treatment zones (MTZs) in an array pattern, while surrounding tissue remains intact |
| Injury Characteristics | Large-area, continuous injury | Spot-like, spaced injury (covers only 3-40% of skin) |
| Healing Source | Relies on slow migration from healthy tissue at the margins | Each micro-injury zone is surrounded by healthy tissue, allowing rapid repair from all sides |
| Recovery Time | Ablative lasers require 1-2 weeks or longer | Non-ablative fractional: just hours to 2-3 days |
| Side Effect Risk | Higher (hyperpigmentation, scarring, infection) | Significantly lower (preserves abundant healthy tissue as a "repair reservoir") |
In 2004, Drs. Manstein and Anderson from the Wellman Center for Photomedicine at Harvard University first introduced the concept of "fractional photothermolysis," laying the theoretical foundation for fractional lasers.
In the 1927nm non-ablative fractional thulium laser, energy is efficiently absorbed by water, creating inverted cone-shaped zones of coagulated tissue in the epidermis and superficial dermis. Within one day post-procedure, these zones form "microscopic epidermal necrotic debris" (MENDs) – tiny particles containing melanin and thermally denatured keratin. MENDs gradually migrate to the stratum corneum and are shed within 7 days, while the underlying healthy epidermis rapidly regenerates. This process achieves the triple synchronization of "pigment removal + epidermal reconstruction + collagen neogenesis."
The water absorption coefficient of the 1927nm thulium laser is approximately 10 times that of the 1550nm erbium glass laser, but much lower than that of ablative CO₂ lasers. This means:
Key parameters of fractional lasers include spot size, coverage density, and pulse energy. Physicians can flexibly combine them based on the patient's primary concern (mainly pigment vs. mainly texture vs. hair loss):
This modular design allows the 1927nm laser to serve both cosmetic and therapeutic tasks.
Peer-reviewed clinical studies or systematic reviews
| Application Area | Specific Indications | Key Findings & Data |
|---|---|---|
| Pigmentary disorders | Melasma, solar lentigo, post-inflammatory hyperpigmentation | MASI score improvement 28–45%; combination with tranexamic acid maintains results for 3 months; safe in darker skin types (III–VI) |
| Actinic keratosis | Facial AK (precancerous lesions) | After 4 treatments at 6 months, AK lesion count reduced by 86.6%; histological clearance rate 85.7% |
| Skin rejuvenation | Facial and periorbital fine lines, pores, dull complexion | Significant improvement in skin brightness (L* value) and pigment score after 3 treatments; better wrinkle improvement with 4-week interval; adverse effects resolved within 7 days |
| Atrophic scars | Acne scars, surgical scars | Significant improvement in scar smoothness and texture; comparable efficacy to 2940nm Er:YAG laser but with shorter recovery time |
| Androgenetic alopecia | Male/female pattern hair loss | After 12 weekly treatments, hair density and thickness significantly increased (P<0.001), effects maintained for 3 months; improvement seen after just 2 treatments |
| Laser-assisted drug delivery | Combination with growth factors, tranexamic acid, salicylic acid, etc. | Laser+growth factor side: 28% increase in hair count from baseline; combination with salicylic acid significantly increased dermal thickness |
The 1927nm thulium laser effectively improves atrophic acne scars and surgical scars. A prospective split-face study demonstrated efficacy comparable to the 2940nm Er:YAG laser, but with less pain and a shorter recovery period.
The 1927nm thulium laser can open numerous microchannels (diameter ~6–130 μm) without disrupting the stratum corneum, greatly enhancing absorption of topical agents.
Across various studies totaling over 500 patients, the most common adverse effects of the 1927nm thulium laser were mild, transient erythema and edema (incidence ~30–50%), typically resolving within 24–72 hours. Hyperpigmentation occurred in less than 5% of cases, and no permanent scarring or visual impairment was reported. Multiple systematic reviews confirm its safety in darker skin types.
As a "microchannel platform," the 1927nm thulium laser can be combined with:
With the miniaturization of fiber lasers, low-energy 1927nm thulium laser home-use devices are already in development. In the future, combined with AI skin analysis, a closed loop of "home detection + precision treatment" could become a reality.
The 1927nm non-ablative fractional thulium laser, with its precise water absorption characteristics, fractional micro‑damage design, and platform capability for laser‑assisted drug delivery, has evolved from a simple "epidermal resurfacing tool" into a versatile powerhouse covering pigmentation, photoaging, scars, hair loss, and more. Its greatest appeal lies in awakening the skin's own regenerative potential at minimal cost.
*Note: This article is based on published academic literature and aims to convey cutting-edge information on laser aesthetic medicine. For specific treatment plans, please consult a qualified physician.*
UltraPixel Dual 1550/1927 Thulium Laser Features
Buying Guide for Professional Laser Hair Removal Machines 2026
Learn Differences Between DPL vs IPL vs SHR Hair Removal
How to Install & Set Up TITANsVS4 Laser Hair Removal Machine
How to Install & Set Up TITANsVS4 Laser Hair Removal Machine
English 
Español 
Русский 
